spacer
home > ebr > winter 2003 > editor's letter
PUBLICATIONS
European Biopharmaceutical Review

Editor's Letter

As we round up 2003, the European biotechnology sector looks ahead to 2004 with somewhat more optimism than it faced entering 2003. This appears to be the message in the marketplace, permeating numerous conference floors and news stories in recent weeks - not least the grand finale, the inaugural CORDIA-EuropaBio Convention, held in Vienna in December 2003 and reviewed later in this issue.

Whilst recent figures from Ernst & Young on European venture investment cite a decline in activity between Q2 and Q3 this year, the UK is highlighted as the exception to this negative picture potentially marking an upturn across Europe with an increase of 52 per cent


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Senior Consultant at Technomark Consulting Services
spacer
Dr Helen Abbott
spacer
spacer
spacer
Amy Curtis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

Speciality Logistics Outlook 2015

World Courier

To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement